ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
We don’t know what the future will bring, but we do know that it will be molded by well-trained, bright minds with good ideas who have the resources to be successful.
My colleagues and I share highlights from a successful and well-publicized breast cancer awareness campaign in Lebanon, focused around International Women's Day.
I am pleased to share the news that ASCO volunteers, staff, and collaborators are already making progress on major expansions to ASCO's programs to address global oncology priorities.
BBCC5 offered didactic sessions with presentations on recent advances in breast cancer research and management and 1-hour tumor board sessions where a panel of experts and the audience discuss real cases of patients with breast cancer.
For World Cancer Day, Dr. Edward L. Trimble hopes you will join him in being an advocate for evidence-based policy changes, and the research that supports them.
For World Cancer Day, Dr. Sana Al Sukhun invites the oncology community to challenge perceptions that cancer is inevitable and encourage healthy lifestyle choices.
As ASCO and the oncology community prepare for World Cancer Day on February 4, 2017, I've been reflecting on the day's theme of "We can. I can," which recognizes the individual responsibilities and opportunities that are built on the advances we make collectively.
Dr. Maher Saifo, an oncologist practicing in Syria, discusses how the Syrian war is affecting cancer care in a post written with his patient, Lama Meer Yousef. Together, they share their story of survival and hope against incredible odds.
Dr. Rita Saroufim, and Dr. Sarah Daouk, and I helped high school students put their science lessons into real-world context during a presentation on breast cancer awareness.
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Inequalities, especially in health care, breed discontent. We need better ways to continue incentivizing the development of new drugs while optimizing access. Biosimilars help, but they won't solve the whole problem.
ASCO CEO Dr. Clifford Hudis describes the Society's Global Oncology programs and the initiatives of the Global Oncology Leadership Task Force. Dr. Hudis asks challenging questions about providing optimal cancer care in low-income countries.
The region has seen structural reforms in health care systems, better training of cancer professionals, new initiatives for populations at high risk, expansion of cancer registries and cancer plans, and implementation of policies to improve prevention, early diagnosis, and treatment.
Blogs
ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
No Results.
Pages
Advertisement